SultanSAcharyaYHynesN.The 4-D in management of complex aortic pathology. Ital J Vasc Endovasc Surg. 2020;27:105–107.
2.
SultanSAcharyaYHynesN.Commentary: When promising innovators lack strategic vision: the concept of flow modulation in aortic dissection. J Endovasc Ther. 2021;28(1):32–35.
3.
RogersEM.Diffusion of Innovations. Free Press; 1995.
4.
JohnsonDM.Three kinds of competitive excellence. J Philos Sport. 2020;47:200–216.
5.
ParodiJC.The challenges of medical innovation. J Vasc Surg. 2020;71:212–215.
6.
de AnaFJUmsteadKAPhillipsGJ, et al. Value driven innovation in medical device design: a process for balancing stakeholder voices. Ann Biomed Eng. 2013;41:1811–1821.
7.
JarosławskiSSaberwalG.Case studies of innovative medical device companies from India: barriers and enablers to development. BMC Health Serv Res. 2013;13:199.
8.
CourvoisierA.The future of academic innovation in the field of medical devices: is innovation still possible in orthopedics?Expert Rev Med Devices. 2016;13:807–813.
9.
MasJPHsuehB.An investor perspective on forming and funding your medical device start-up. Tech Vasc Interv Radiol. 2017;20:101–108.
10.
KonishiAIsobeSSatoD.New regulatory framework for medical devices in Japan: current regulatory considerations regarding clinical studies. J Vasc Interv Radiol. 2018;29:657–660.
11.
XuSAvornJKesselheimAS.Origins of medical innovation: the case of coronary artery stents. Circ Cardiovasc Qual Outcomes. 2012;5:743–749.
12.
AkpinarIOhinmaaAThordingL, et al. The costs of industry-sponsored medical device clinical trials in Alberta. Pharmacoecon Open. 2019;3:591–597.
13.
ZippelCBohnet-JoschkoS.Innovation for safe and effective medical devices: contributions from postmarket surveillance. Ther Innov Regul Sci. 2017;51:237–245.
14.
AlexanderAMcGillMTarasovaA, et al. Scanning the future of medical imaging. J Am Coll Radiol. 2019;16:501–507.
15.
CoutoDSPerez-BrevaLSaraivaP, et al. Lessons from innovation in drug-device combination products. Adv Drug Deliv Rev. 2012;64:69–77.
16.
BruzziMSLinehanJH.BioInnovate Ireland—fostering entrepreneurial activity through medical device innovation training. Ann Biomed Eng. 2013;41:1834–1840.
17.
KesselheimASXuSAvornJ.Clinicians’ contributions to the development of coronary artery stents: a qualitative study of transformative device innovation. PLoS One. 2014;9:e88664.
18.
WongKAHodgsonLGarasG, et al. How can cardiothoracic and vascular medical devices stay in the market?Interact Cardiovasc Thorac Surg. 2016;23:940–948.
19.
PironC.Key conditions for successful serial entrepreneurship in healthcare. Healthc Pap. 2017;16:52–57.
20.
AngelosP.Ethics and surgical innovation: challenges to the professionalism of surgeons. Int J Surg. 2013;11(suppl 1):S2–S5.
21.
TsuchiiI.Future regulatory science through a global product development strategy to overcome the device lag [in Japanese]. Yakugaku Zasshi. 2016;136:531–535.
22.
Van HauteA. Managing perceived conflicts of interest while ensuring the continued innovation of medical technology. J Vasc Surg. 2011;54(3 suppl):31S–3S.
23.
MaresovaPHajekLKrejcarO, et al. New regulations on medical devices in Europe: are they an opportunity for growth?Adm Sci. 2020;10:16.
24.
HarmonSHEBrownAPopatS, et al. Body extension and the law: medical devices, intellectual property, prosthetics and marginalisation (again). Law Innov Technol. 2018;10:161–184.
25.
Dores CruzTDBeersmaBDijkstraMTM, et al. The bright and dark side of gossip for cooperation in groups. Front Psychol. 2019;10:1374.
26.
ChenJPickettTLangellA, et al. Industry-academic partnerships: an approach to accelerate innovation. J Surg Res. 2016;205:228–233.
27.
FearisKPetrieA.Best practices in early phase medical device development: engineering, prototyping, and the beginnings of a quality management system. Surgery. 2017;161:571–575.
28.
SultanSElkadyRBarrettN, et al. Endovascular management of saccular extracranial internal carotid artery aneurysm using transcervical carotid approach and flow reversal. J Vasc Surg Cases Innov Tech. 2019;5:273–277.
29.
DulaiMElsherifMTawfickW, et al. Outcome following open and endovascular intervention for carotid stump syndrome. SAGE Open Med Case Rep. 2018;6:2050313X18779744.
30.
DulaiMTawfickWHynesN, et al. A parallel observational comparative study of cervical carotid artery stenting approach versus groin approach versus carotid endarterectomy in high-risk patients. Int J Sci Res. 2018;7:447–451.
31.
DulaiMTawfickWHynesN, et al. Risk factors for recurrent carotid artery stenosis following surgical interventions. Int J Sci Res. 2018;7:467–471.
32.
UnderhillK. When extrinsic incentives displace intrinsic motivation: designing legal carrots and sticks to confront the challenge of motivational crowding-out. Yale J Reg. 2016:33.
33.
PanneGVDBeersCVKleinknechtA. Success and failure of innovation: a literature. Int J Innov Manage. 2003;7:309–338.
MaresovaPPenhakerMSelamatA, et al. The potential of medical device industry in technological and economical context. Ther Clin Risk Manag. 2015;11:1505–1514.
36.
VollmerSMateenBABohnerG, et al. Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness. BMJ. 2020;368:16927.
37.
PriceWN2ndCohenIG.Privacy in the age of medical big data. Nat Med. 2019;25:37–43.
DuongDBSullivanEEMinter-JordanM, et al. A model for training medical student innovators: the Harvard Medical School Center for Primary Care Abundance Agents of Change program. Med Educ Online. 2016;21:30662.
40.
XuSXuRSBreslinJ, et al. Professional medical associations and the opportunity to promote breakthrough biomedical innovation. Drug Discov Today. 2018;23:1453–1456.
